Showing results (271-280 of 292) with videos related to
Sort By:
Pageof 30
BMC Public Health|February 27, 2024
Social factors associated with self-reported changes in mental health symptoms among youth in the COVID-19 pandemic: a cross-sectional surveyStephana Julia Moss, Maia Stelfox, Eric McArthur, et al.Human Vaccines & Immunotherapeutics|February 23, 2024
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent dosesJeanna Parsons Leigh, Emily A FitzGerald, Stephana Julia Moss, et al.Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420May S ElSherif, Kara L Redden, Joanne M Langley, et al.Human Vaccines & Immunotherapeutics|January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in CanadaTiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.CMAJ Open|December 23, 2017
Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocolShelly Bolotin, Caitlin Johnson, Susan Quach, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.Vaccine|September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trialGlenn Hamonic, Elodie Pastural, Supriya Arora, et al.The Journal of Pediatrics|August 10, 2022
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following ImmunizationCaroline E Muñoz, Beth MacDonald, Anne Pham-Huy, et al.The Journal of Infectious Diseases|July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in childrenJoanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care ProvidersEve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.Pageof 30